Matches in SemOpenAlex for { <https://semopenalex.org/work/W3028932267> ?p ?o ?g. }
Showing items 1 to 76 of
76
with 100 items per page.
- W3028932267 endingPage "486" @default.
- W3028932267 startingPage "484" @default.
- W3028932267 abstract "ObjectiveTo investigate the clinical efficacy of allicin in the treatment of acute exacerbation of bronchiectasis.MethodsIncluded in this study were 120 patients with acute exacerbation of bronchiectasis admitted to our hospital between October 2015 and October 2017. Using a random number table, the patients were assigned to a control group (n=60) or a study group (n=60) . The control group received routine treatment, while the study group received oral allicin in addition to the routine treatment. Before and at 1 week after treatment, inflammatory biomarkers in the two groups were examined, including serum C-reactive protein (CRP) , procalcitonin (PCT) , and neutrophil percentage (N%) . At 1 week after treatment, the clinical efficacy was evaluated and the occurrence of treatment-related adverse reactions was recorded.ResultsAfter treatment, serum levels of CRP and PCT, and N% were significantly lowered in the both groups from baseline (all P<0.05) . Compared with the control group, the post-treatment serum levels of CRP and PCT, and N% in the study group were significantly lower (all P<0.05) . The effective rates of treatment in the study group vs the control group were 66.7% (40/60) vs 58.3% (35/60) , with no significant difference between two groups (χ2=0.889, P=0.346) . Gastrointestinal reactions occurred in 3 patients in the study group, and they all resolved after discontinuation of allicin. There were no obvious adverse reactions in the control group.ConclusionAllicin as an add-on treatment may be beneficial for patients with acute exacerbation of bronchiectasis with modest adverse reactions.Key words: Allicin; Bronchiectasis; Treatment outcome; Adverse effects" @default.
- W3028932267 created "2020-06-05" @default.
- W3028932267 creator A5006012404 @default.
- W3028932267 creator A5048740236 @default.
- W3028932267 date "2017-12-15" @default.
- W3028932267 modified "2023-10-18" @default.
- W3028932267 title "Allicin as an add-on treatment in acute exacerbation of bronchiectasis: a clinical study" @default.
- W3028932267 doi "https://doi.org/10.3760/cma.j.issn.1674-1927.2017.06.009" @default.
- W3028932267 hasPublicationYear "2017" @default.
- W3028932267 type Work @default.
- W3028932267 sameAs 3028932267 @default.
- W3028932267 citedByCount "0" @default.
- W3028932267 crossrefType "journal-article" @default.
- W3028932267 hasAuthorship W3028932267A5006012404 @default.
- W3028932267 hasAuthorship W3028932267A5048740236 @default.
- W3028932267 hasConcept C10936531 @default.
- W3028932267 hasConcept C126322002 @default.
- W3028932267 hasConcept C178790620 @default.
- W3028932267 hasConcept C185592680 @default.
- W3028932267 hasConcept C197934379 @default.
- W3028932267 hasConcept C2776914184 @default.
- W3028932267 hasConcept C2777014857 @default.
- W3028932267 hasConcept C2777714996 @default.
- W3028932267 hasConcept C2778384902 @default.
- W3028932267 hasConcept C2778715236 @default.
- W3028932267 hasConcept C2779379686 @default.
- W3028932267 hasConcept C2781005338 @default.
- W3028932267 hasConcept C2781195455 @default.
- W3028932267 hasConcept C71924100 @default.
- W3028932267 hasConcept C90924648 @default.
- W3028932267 hasConceptScore W3028932267C10936531 @default.
- W3028932267 hasConceptScore W3028932267C126322002 @default.
- W3028932267 hasConceptScore W3028932267C178790620 @default.
- W3028932267 hasConceptScore W3028932267C185592680 @default.
- W3028932267 hasConceptScore W3028932267C197934379 @default.
- W3028932267 hasConceptScore W3028932267C2776914184 @default.
- W3028932267 hasConceptScore W3028932267C2777014857 @default.
- W3028932267 hasConceptScore W3028932267C2777714996 @default.
- W3028932267 hasConceptScore W3028932267C2778384902 @default.
- W3028932267 hasConceptScore W3028932267C2778715236 @default.
- W3028932267 hasConceptScore W3028932267C2779379686 @default.
- W3028932267 hasConceptScore W3028932267C2781005338 @default.
- W3028932267 hasConceptScore W3028932267C2781195455 @default.
- W3028932267 hasConceptScore W3028932267C71924100 @default.
- W3028932267 hasConceptScore W3028932267C90924648 @default.
- W3028932267 hasIssue "6" @default.
- W3028932267 hasLocation W30289322671 @default.
- W3028932267 hasOpenAccess W3028932267 @default.
- W3028932267 hasPrimaryLocation W30289322671 @default.
- W3028932267 hasRelatedWork W2351965508 @default.
- W3028932267 hasRelatedWork W2356695447 @default.
- W3028932267 hasRelatedWork W2363414306 @default.
- W3028932267 hasRelatedWork W2363727978 @default.
- W3028932267 hasRelatedWork W2366229848 @default.
- W3028932267 hasRelatedWork W2369552604 @default.
- W3028932267 hasRelatedWork W2373745028 @default.
- W3028932267 hasRelatedWork W2375494388 @default.
- W3028932267 hasRelatedWork W2385873486 @default.
- W3028932267 hasRelatedWork W2389252801 @default.
- W3028932267 hasRelatedWork W2393016513 @default.
- W3028932267 hasRelatedWork W2562287737 @default.
- W3028932267 hasRelatedWork W3029075822 @default.
- W3028932267 hasRelatedWork W3029221359 @default.
- W3028932267 hasRelatedWork W3029988848 @default.
- W3028932267 hasRelatedWork W3030127852 @default.
- W3028932267 hasRelatedWork W3032507643 @default.
- W3028932267 hasRelatedWork W3116492362 @default.
- W3028932267 hasRelatedWork W3183608382 @default.
- W3028932267 hasRelatedWork W3018840505 @default.
- W3028932267 hasVolume "23" @default.
- W3028932267 isParatext "false" @default.
- W3028932267 isRetracted "false" @default.
- W3028932267 magId "3028932267" @default.
- W3028932267 workType "article" @default.